{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:57:59Z","timestamp":1793159879183,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18YF1423600"],"award-info":[{"award-number":["18YF1423600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09201004-002"],"award-info":[{"award-number":["2019ZX09201004-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["18XD1403700"],"award-info":[{"award-number":["18XD1403700"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872981"],"award-info":[{"award-number":["81872981"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807052"],"award-info":[{"award-number":["21807052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZY(2018-2020)-CCCX-2001-04"],"award-info":[{"award-number":["ZY(2018-2020)-CCCX-2001-04"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["17401901900"],"award-info":[{"award-number":["17401901900"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bioorg.2021.104685","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:27:54Z","timestamp":1612290474000},"page":"104685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson\u2019s disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Feng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Sai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shuai","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104685_b0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-7091-6499-0_28","article-title":"Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey","author":"Finberg","year":"1998","journal-title":"J. Neural Transmission-Supplement"},{"key":"10.1016\/j.bioorg.2021.104685_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2021.104685_b0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s007020200064","article-title":"Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems","volume":"109","author":"Carlsson","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bioorg.2021.104685_b0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/NDT.S32302","article-title":"Review: management of Parkinson's disease","volume":"9","author":"Pedrosa","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bioorg.2021.104685_b0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1742-1241.2009.02027.x","article-title":"Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis","volume":"63","author":"Talati","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bioorg.2021.104685_b0030","first-page":"1132","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration","volume":"2017","author":"Jha","year":"1863","journal-title":"Biochimica Et Biophysica Acta-Molecular Basis of Disease"},{"key":"10.1016\/j.bioorg.2021.104685_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0161-813X(03)00095-0","article-title":"Monoamine oxidase expression during development and aging","volume":"25","author":"Nicotra","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bioorg.2021.104685_b0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2021.104685_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2021.104685_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","article-title":"Therapies in Parkinson's disease","volume":"25","author":"Jankovic","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bioorg.2021.104685_b0055","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1021\/jm501722s","article-title":"Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease","volume":"58","author":"Huleatt","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmech.2018.01.003","article-title":"Privileged scaffolds as MAO inhibitors: Retrospect and prospects","volume":"145","author":"Tripathi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0065","doi-asserted-by":"crossref","first-page":"49764","DOI":"10.1039\/C6RA05262B","article-title":"Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold","volume":"6","author":"Fonseca","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2021.104685_b0070","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/jm200716y","article-title":"Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors","volume":"54","author":"Matos","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0075","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1021\/jm001028o","article-title":"Inhibition of monoamine oxidases by functionalized coumarin derivatives: Biological activities, QSARs, and 3D-QSARs","volume":"43","author":"Gnerre","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0080","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/jm801496u","article-title":"Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins","volume":"52","author":"Chimenti","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioorg.2017.11.009","article-title":"Design, synthesis and evaluation of resveratrol-indazole hybrids as novel monoamine oxidases inhibitors with amyloid-beta aggregation inhibition","volume":"76","author":"Lan","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.07.055","article-title":"Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"139","author":"Lan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/C6MD00586A","article-title":"Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors","volume":"8","author":"Lan","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2021.104685_b0100","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.2147\/DDDT.S86225","article-title":"2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors","volume":"9","author":"Legoabe","year":"2015","journal-title":"Drug Design Development and Therapy"},{"key":"10.1016\/j.bioorg.2021.104685_b0105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C5MD00124B","article-title":"Chromanones: selective and reversible monoamine oxidase B inhibitors with nanomolar potency","volume":"6","author":"Lan","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2021.104685_b0110","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.bmcl.2014.04.021","article-title":"alpha-Tetralone derivatives as inhibitors of monoamine oxidase","volume":"24","author":"Legoabe","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104685_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2012.08.003","article-title":"Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors","volume":"45","author":"Legoabe","year":"2012","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2012.01.037","article-title":"Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives","volume":"49","author":"Legoabe","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bmcl.2013.01.003","article-title":"Inhibition of monoamine oxidase by phthalide analogues","volume":"23","author":"Strydom","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104685_b0130","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/j.bmcl.2013.08.071","article-title":"Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives","volume":"23","author":"Meiring","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104685_b0135","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1021\/acs.joc.6b02207","article-title":"Systematic Investigation into the Matsuda-Heck Reaction of alpha-Methylene Lactones: How Conformational Constraints Direct the beta-H-Elimination Step","volume":"81","author":"Schmidt","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","article-title":"Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease","volume":"95","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0145","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/jm500729a","article-title":"Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency","volume":"57","author":"Tzvetkov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1039\/C3OB42010H","article-title":"Design, synthesis and evaluation of novel tacrine rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"12","author":"Li","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2019.04.016","article-title":"Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease","volume":"173","author":"Tao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103707","article-title":"Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease","volume":"97","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0165","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.bmc.2016.09.050","article-title":"Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: Towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2021.104685_b0175","unstructured":"http:\/\/www.molinspiration.com\/services\/properties.html (accessed August 2016)."},{"key":"10.1016\/j.bioorg.2021.104685_b0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","article-title":"Alzheimer's disease drug development and the problem of the blood-brain barrier","volume":"5","author":"Pardridge","year":"2009","journal-title":"Alzheimers Dementia"},{"key":"10.1016\/j.bioorg.2021.104685_b0185","article-title":"Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-beta Species in Alzheimer's Disease","volume":"2010","author":"Braymer","year":"2011","journal-title":"Int. J. Alzheimer's Disease"},{"key":"10.1016\/j.bioorg.2021.104685_b0190","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0195","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acschemneuro.7b00050","article-title":"Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease","volume":"8","author":"Nam","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2021.104685_b0200","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm401788m","article-title":"Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy","volume":"57","author":"Woo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104685_b0205","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jnr.23577","article-title":"1- 2-(4-Benzyloxyphenoxy)Ethyl Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease","volume":"93","author":"Chung","year":"2015","journal-title":"J. Neurosci. Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:33:56Z","timestamp":1778628836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"alternative-id":["S0045206821000614"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104685","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104685"}}